Objective- the study aim to determine the cardiac patient knowledge about anticoagulant medications using and its relationship with demographic data(age. gender. level of education. occupational). Methodology- A descriptive study(quasi-experimental)design was carried out to determine cardiac patient knowledge consider to using anticoagulant medications . Starting from(1th Jun 2017 to5th October 2018).To achieve the objectives of the study, a non-probability sample (a purposive sample) consisted of random sample comprised of (30) patients were taken anticoagulant medications ..The measurement of patient knowledge were collected through the use of questionnaire which is related to patient knowledge toward using the anticoagulant medications. The questionnaire was interview with cardiac patients who were attended coronary care unit at Al-Sadder Teaching Hospital, and Missan Center of Cardiac Disease and in the Medical Consulting after obtaining agreement from the patients throughout using arabic version of questionnaire. The researcher conducted private meeting with each patient who spends about 25-30 minute to respond to the interview which were developed for the purpose of the study. Instrument validity was determined through content validity, by a panel of experts. Reliability of the instrument was determined through the use of Cronbach Alfa which was (0.85) which are strong acceptable for acute myocardial infarction patients'. Analysis of data was performed through the application of descriptive statistics (frequency, percentage) and inferential statistics (t-test and one way analysis of variance) . Result. when we using mean of score the study showed that low level of knowledge for some items and moderate level of knowledge to other items when ( Low 0.0-0.33) (Moderate 0.34-0.76) (0.67-1.0High).and the result study showed no significant differences between cardiac patient knowledge and demographic data (age, gender ,level of education, occupational) . Recommendation-The researchers recommend the implementation of continuous education programs for cardiac patient about using anticoagulant drugs
(31)
(32)
(1)
(1)
The objective of the present investigation was to enhance the solubility of practically insoluble mirtazapine by preparing nanosuspension, prepared by using solvent anti solvent technology. Mirtazapine is practically insoluble in water which act as antidepressant .It was prepared as nano particles in order to improve its solubility and dissolution rate. Twenty formulas were prepared and different stabilizing agents were used with different concentrations such as poly vinyl pyrrolidone (PVPK-90), poly vinyl alcohol (PVA), poloxamer 188 and poloxamer 407. The ratios of drug to stabilizers used to prepare the nanoparticles were 1: 1 and 1:2. The prepared nanoparticles were evaluated for
... Show More
(26)
(15)
(2)
(4)
(2)
(1)
(300)
(284)
Abstract: The article aimed to formulate an MLX binary ethosome hydrogel for topical delivery to escalate MLX solubility, facilitate dermal permeation, avoid systemic adverse events, and compare the permeation flux and efficacy with the classical type. MLX ethosomes were prepared using the hot method according to the Box–Behnken experimental design. The formulation was implemented according to 16 design formulas with four center points. Independent variables were (soya lecithin, ethanol, and propylene glycol concentrations) and dependent variables (vesicle size, dispersity index, encapsulation efficiency, and zeta potential). The design suggested the optimized formula (MLX−Ethos−OF) with the highest desirability to perform the
... Show More
(12)
(23)
(25)
(1)
(1)
Objectives: To study the spectrum and classification of ATP7B variants in Iraqi children with Wilson disease by direct gene sequencing with clinical correlation. Methods: Fifty-five unrelated children with a clinical diagnosis of Wilson disease (WD) were recruited. Deoxyribonucleic acid was extracted from peripheral blood samples, and variants in the ATP7B gene were identified using next-generation sequencing. Results: Seventy-six deleterious variants were detected in 97 out of 110 alleles of the ATP7B gene. Thirty (54.5%) patients had 2 disease-causing variants (15 homozygous and 15 compound heterozygous). Twelve (21.8%) patients had one disease-causing variant and one variant of uncertain significance (VUS) with potential pathogenicity. T
... Show More
(2)